Invega sustenna and Soliloquy - a phase IV clinical study of FDA data

Summary:

Soliloquy is reported as a side effect among people who take Invega sustenna (paliperidone palmitate), especially for people who are male, 30-39 old, have been taking the drug for 6 - 12 months also take Invega, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Soliloquy when taking Invega sustenna. It is created by eHealthMe based on reports of 23,130 people who have side effects when taking Invega sustenna from the FDA, and is updated regularly.

What is Invega sustenna?

Invega sustenna has active ingredients of paliperidone palmitate. It is often used in schizophrenia. eHealthMe is studying from 23,232 Invega sustenna users. Check the latest studies of Invega sustenna.

What is Soliloquy?

Soliloquy is found to be associated with 109 drugs and 233 conditions by eHealthMe. Check the latest studies of Soliloquy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

23,130 people reported to have side effects when taking Invega sustenna.
Among them, 30 people (0.13%) have Soliloquy.

Among these 30 people:

How long have people been on Invega sustenna when they have Soliloquy? *

What is the gender of people who have Soliloquy when taking Invega sustenna? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Soliloquy when taking Invega sustenna? *

What are other drugs people take besides Invega sustenna? *

What are other side effects people have besides Soliloquy? *

Hallucination, Auditory (perceiving sounds without auditory stimulus): 9 people, 30.00%
Hallucinations (sensations that appear real but are created by your mind): 6 people, 20.00%
Abnormal Behavior: 5 people, 16.67%
Delusion (a false belief or opinion): 4 people, 13.33%
Weight Increased: 4 people, 13.33%
Aggression: 3 people, 10.00%
Agitation (state of anxiety or nervous excitement): 3 people, 10.00%
Insomnia (sleeplessness): 3 people, 10.00%
Pain: 3 people, 10.00%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 6.67%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 3 people, 10.00%
Sleep Disorder: 1 person, 3.33%
Pain: 1 person, 3.33%
Multiple Allergies (allergy to multiple agents): 1 person, 3.33%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Invega sustenna and have Soliloquy?

- Check whether Soliloquy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invega sustenna:

Invega sustenna (23,232 reports)

Soliloquy treatments and more:

Soliloquy (942 reports)

Browse all side effects of Invega sustenna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Soliloquy:

Soliloquy (109 drugs)

Browse all the conditions that are associated with Soliloquy:

Soliloquy (233 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Invega sustenna) and Invega sustenna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.